Association of human height-related genetic variants with familial short stature in Han Chinese in Taiwan

Article metrics

Abstract

Human height can be described as a classical and inherited trait model. Genome-wide association studies (GWAS) have revealed susceptible loci and provided insights into the polygenic nature of human height. Familial short stature (FSS) represents a suitable trait for investigating short stature genetics because disease associations with short stature have been ruled out in this case. In addition, FSS is caused only by genetically inherited factors. In this study, we explored the correlations of FSS risk with the genetic loci associated with human height in previous GWAS, alone and cumulatively. We systematically evaluated 34 known human height single nucleotide polymorphisms (SNPs) in relation to FSS in the additive model (p < 0.00005). A cumulative effect was observed: the odds ratios gradually increased with increasing genetic risk score quartiles (p < 0.001; Cochran-Armitage trend test). Six affected genes—ZBTB38, ZNF638, LCORL, CABLES1, CDK10, and TSEN15—are located in the nucleus and have been implicated in embryonic, organismal, and tissue development. In conclusion, our study suggests that 13 human height GWAS-identified SNPs are associated with FSS risk both alone and cumulatively.

Introduction

Human height can be described as a classical, inherited, and polygenic trait model. The ultimate phenotype represents the outcome of genetics and developmental biology, including the enlargement of bone length and the sizes of tissues and organ sizes. Undoubtedly, the developmental processes may be affected by environmental factors, including nutrition1, exercise2, diseases3,4,5, and infections6, 7. However, ~80% of the variance in height among individuals can also be explained by genetic variation8,9,10. Modern high-density genotyping platforms have now made it possible to identify candidate genes across the whole genome in relation to complex traits and diseases11,12,13.

Genetic factors that contribute to the genetic architecture of human height are widely identified by means of genome-wide screening methods14,15,16,17,18,19,20,21,22,23,24. Human height-related susceptibility loci related to the protein tyrosine phosphatase family, insulin-like growth factor, and skeletal growth have been reported in Asian populations18, 19, 21, 22, 25. In addition, predisposing loci determining height have also been discovered in European populations in genes related to skeletal development, mitosis, fibroblast growth factors, the WNT/β-catenin pathway, chondroitin sulfate-related genes, mammalian target of rampamycin, osteoglycin, binding of hyaluronic acid, Hedgehog signaling, the extracellular matrix, and cancer-associated pathways14,15,16,17. The results of genome-wide association studies (GWAS) have thus contributed new information on the susceptibility loci related to human height and provide insights into the extreme polygenic nature of human height.

Short stature is defined as a body height below the 3rd percentile for the corresponding age and gender of the population. Among people affected by short stature, 37% have familial short stature (FSS), 27% have a constitutional growth delay, 17% have both FSS and a constitutional growth delay, 9% have a systemic disease, 5% have an endocrine condition, and the cause is unknown in the remaining 5% of cases26,27,28. Representing the majority of cases of short stature, FSS is characterized by a height below the 3rd percentile in the population, a normal annual growth rate, normal bone age, family history of short stature, normal onset of puberty, and normal results of biochemical analyses. FSS is also called “genetic short stature” because the growth conditions are normal but the body height is below the 3rd percentile and there is a family history of short stature. FSS represents a very suitable study object for research on short stature genetics because disease association has been ruled out for the short stature in FSS. FSS is caused only by genetically inherited factors. Thus, we initiated a pilot study to search for genetic loci that may predispose individuals to FSS. We explored the associations of FSS risk in Taiwan with genetic loci that have been related to human height according to previous GWAS, both alone and cumulatively.

Results

GWAS-determined genetic variants related to human height and FSS risk in the Han Chinese population of Taiwan

To identify the susceptible single nucleotide polymorphisms (SNPs) associated with FSS risk, we chose genetic SNPs that have been related to human height according to published GWAS, which were considered to be the closest genes potentially associated with FSS. There were 1,033 genetic SNPs reported in 14 human height GWAS conducted to date (Table S1). Of these, 34 SNPs were ultimately identified as candidate susceptibility SNPs for FSS according to the selection criteria [call rates of genotyping for both FSS and controls >95%, genotypes for genetic variants in controls conforming to Hardy-Weinberg equilibrium (p > 0.05), and p-value for the additive model <5.00E-05 (0.05/1,033)]. The 34 SNPs in 15 closest genes identified in human height GWAS are summarized in Table 1 and Supplementary Table S2. As shown in Table 1, the minor allele frequencies (MAFs) of these 34 genetic SNPs were similar to the MAFs in Han Chinese from Beijing (CHB) NCBI GRCh38.p2 assembly) from the online database of the dbSNP website (HAPMAP-CHB; http://www.ncbi.nlm.nih.gov/projects/SNP/index.html). The pair-wise linkage disequilibrium (LD) between the 34 SNPs was also estimated (Supplementary Tables S2S5 and Figure S1).

Table 1 Information of genetic SNPs identified from GWAS of human height.

The excluded SNPs were those with strong LD (D′ > 0.8). According to the LD results, we then re-selected these SNPs for calculation of the cumulative effect. The re-selected SNPs included 13 SNPs in the 13 closest genes: rs1046934 in TSEN15, rs3791679 in EFEMP1, rs3771381 in ZNF638, rs10935120 in CEP63, rs7632381 in ZBTB38, rs13131350 in LCORL, rs6845999 in HHIP, rs4240326 in ANAPC10, rs6470764 in GSDMC, rs12338076 in QSOX2, rs4842838 in ADAMTSL3, rs258324 in CDK10, and rs4308051 in CABLES1. The association was statistically evaluated by the odds ratio (OR) and its corresponding 95% confidence interval (CI) in the additive genetic model. As shown in Table 2, these 13 genetic SNPs showed a statistically significant association with FSS risk (p-value < 0.00005).

Table 2 Association between human height related genetic SNPs and familial short stature occurrence.

Cumulative effects of the 13 human height genetic SNPs on FSS risk

In accordance with the potential additive inheritance model for the individual SNP association analysis (Table 2), we subdivided the three genotypes of each SNP into three groups: risk allele homozygote (the risk genotype is coded as “2”), risk allele heterozygote (the risk genotype is coded as “1”), and Non-risk allele homozygote (the non-risk genotype is coded as “0”) (Table S6, Figures S2 and S3). We calculated the multi-locus genetic risk score (GRS) for each individual by summing the number of risk alleles (0/1/2) for each of the 13 SNPs weighted by their estimated effect sizes (log OR) (Table S6 and Figure S3). Estimates of the association between the weighted GRS divided into quartiles (Q1–Q4) and FSS were calculated using a logistic regression model; individuals in genetic risk score Q1 served as the reference. As shown in Table 3, there was a continuous increase in FSS risk with the cumulative weighted GRS quartile numbers (p < 0.001; Cochran-Armitage trend test). That is, compared with individuals in Q1, those identified in Q2, Q3, and Q4 had a significant association with increased FSS risk, with an increasing risk for each quartile (Table 3). These results suggested a cumulative effect of these 13 SNPs on FSS risk.

Table 3 Association between genetic risk score from the 13 human height genetic loci and FSS risk

Functional analysis

We applied these 13 SNPs re-selected from the LD results to possible pathway mapping and further functional validation to explore possible functional relations among the genes affected by these 13 SNPs. The network analysis identified a single cluster of 35 genes that included 11 associated genes discovered in this study (Figure S4) related to functions of embryonic development, organismal development, and tissue development. Six of these genes are all located in the nucleus: ZBTB38, ZNF638, LCORL, CABLES1, CDK10, and TSEN15.

Discussion

Human height GWAS have led to the discovery of thousands of novel genetic variants14,15,16,17,18,19,20,21,22,23,24. In this work, we initiated our FSS study on a single ethnic group (Han Chinese) and investigated the associations of FSS risk with genetic variants previously related to human height in GWAS, both alone and cumulatively. We identified a continuous increase in FSS risk with increasing genetic risk score quartiles, suggesting a cumulative effect of these 13 SNPs on FSS risk. These data suggest that FSS represents a suitable research object for investigating short stature genetics. To our knowledge, this is the first study reporting the genetic profile of FSS.

The LD analysis revealed several SNPs in strong LD that have been linked to adult height in previous genetic studies, mapping to genes such as COLGALT2 and TSEN15, EFEMP1 (implicated in bone and cartilage development pathways, including the constitutions of the extracellular matrix), ZBTB38, LCORL, HHIP, ANAPC10, GSDMC, QSOX2, ADAMTSL3, and CABLES1 14, 16,17,18,19,20, 25. Other SNPs were found to be independent, located near the ZNF638 and CEP63 genes. CEP63 recruits the cell cycle regulatory protein CDK1 to the centrosome, and has been associated with regulation of mitotic entry, centrosome amplification, and genome maintenance, thereby affecting cell proliferation. Only one SNP was identified for chromosome 16, related to CDK10.

Network cluster analysis revealed functions of these 13 genes that are mainly related to embryonic development, organismal development, and tissue development. Two of the genes found to be associated with FSS belong to the zinc finger protein family: ZBTB38 and ZNF638. There were seven relevant SNPs in ZBTB38: rs6440003, rs6763931, rs724016, rs7632381, rs1344672, rs9825379, and rs10513137 that have previously been reported in human height GWAS12, 16, 18, 19, 25. Moreover, genetic variants in ZBTB38, including rs724016, rs1582874, rs11919556, rs6440006, rs7612543, rs62282002, and rs18651435, have also been implicated in idiopathic short stature (ISS)29. ZBTB38 encodes a zinc finger- and BTB domain-containing protein 38. It belongs to the family of zinc finger proteins and thus serves as a zinc finger transcriptional activator that binds methylated DNA; such potential suppression of the transcription of methylated regions might affect adult stature by regulating the production of insulin-like growth factor-II30. Therefore, ZBTB38 may affect adult height, ISS, and FSS by regulating the protein expression of IGF-II. In addition, ZBTB38 also regulates the transcription of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis31.

Moreover, the SNP rs3771381 in ZNF638, encoding zinc finger protein 68, was also associated with FSS risk. ZNF638 genetic variants have been reported in human height GWAS25, 32. ZNF638 is a nucleoplasmic protein that binds to cytidine-rich sequences in double-stranded DNA33. This zinc finger protein is a member of the large class of transcription factors that participates in skeletal development34 and regulates adipocyte differentiation35. ZNF638 has been reported to be a transcriptional coregulator of the early regulator of adipogenesis via induction of PPARγ in cooperation with CCAAT/enhancer binding proteins (C/EBPs)35, 36.

LCORL encodes a ligand-dependent nuclear receptor corepressor-like protein and is a transcription factor. Polymorphisms in this gene are associated with measures of skeletal frame size and adult height in human and in livestock animals24, 25, 37,38,39,40. SNPs affecting the transcription or translation of LCORL may result in up- or down-regulation of the expression of genes involved in growth38, and may affect bone formation, skeletal frame size, as well as body height; thus, further functional investigations of these variants are warranted. One SNP (rs13131350) within this gene was associated with FSS in our study. This SNP was also reported in a meta-analysis study of GWAS of adult height in East Asians25. Regulation of LCORL protein expression may affect bone formation, skeletal frame size, as well as body height; thus, further functional investigations are warranted.

There were two cell cycle regulation-related genes—CABLES1 and CDK10—associated with FSS in our study. According to the present study, four SNPs in CABLES1 are associated with FSS in Han Chinese in Taiwan: rs4800452, rs4369779, rs4308051, and rs8094261, which have also been reported in human height GWAS14, 18, 23, 25. CABLES1 encodes a Cdk5 and Abl enzyme substrate protein 1, and serves as a candidate tumor suppressor that negatively regulates cell growth by inhibiting cyclin-dependent kinases41, 42. Loss of CABLES1 protein expression has been observed at high frequency in human colorectal, lung, ovarian, and endometrial hyperplasia and in endometrial cancers42,43,44,45. CABLES1 protein overexpression induces apoptosis and inhibits cell growth by stabilizing p21 and decreasing cyclin-dependent kinase 2 kinase activity, thereby affecting cell proliferation46.

The other cell cycle-regulatory gene is CDK10. We found one SNP (rs258324) located in CDK10 associated with FSS, which was also reported in a human height GWAS25. CDK10 encodes cyclin-dependent kinase 10 and belongs to the CDK subfamily of the family of Ser/Thr protein kinases, which are necessary for cell cycle progression. CDK10 plays important roles in cellular proliferation and in regulation of the G2-M phase of the cell cycle47, 48. Therefore, CABLES1 and CDK10 may affect adult height and FSS by regulating cell survival, cell cycle, and cellular proliferation.

We identified one SNP (rs1046934) in TSEN15 associated with FSS. This SNP has been reported in a human height GWAS study14. TSEN15 encodes a highly conserved subunit of a tRNA-splicing endonuclease that catalyzes the removal of introns from tRNA precursors49, 50. tRNA splicing is a fundamental process for cell growth and division and is highly conserved among vertebrates. Mutations in TSEN15 cause neurogenetic disorders, including pontocerebellar hypoplasia and progressive microcephaly50,51,52. These findings are suggestive of TSEN15′s importance in brain development. However, the roles of TSEN15 in adult height and FSS remain unclear and further functional characterization is needed.

In conclusion, our study suggests that 13 SNPs related to human height (according to previous GWAS) are associated with FSS risk alone and cumulatively. This is the first report on the genetic profile of FSS. Such information may be helpful for further research on short stature in the Han Chinese population, and for future functional studies dealing with growth and development. Confirmatory studies with a larger sample size and with functional characterization of these candidate genes would be warranted in the near future.

Methods

Study participants

The case population consisted of 978 individuals with FSS sequentially enrolled from the Children’s Hospital, China Medical University, Taichung, Taiwan, from August 1999 to September 2014. All participants were unrelated Han Chinese children who were residents of central Taiwan and fulfilled the diagnostic criteria of FSS26, 28. The criteria for FSS in our association study were (1) height less than the 3rd percentile of the corresponding population, (2) normal annual growth rate, (3) bone age appropriate for chronologic age, (4) a family history of short stature, (5) normal onset of puberty, and (6) normal results of physical examination. The controls consisted of 1,129 subjects who were randomly selected from the Taiwan Biobank (http://www.twbiobank.org.tw/new_web/index.php). The criteria for controls for inclusion in our association study were (1) no history of FSS diagnosis, (2) body height above that of the top 75th percentile of the general population in Taiwan; and (3) age <61 years. All the participating FSS cases and controls were of Han Chinese origin, which constitutes 98% of the Taiwanese population. The ethnic background was assigned in accordance with the results of self-reported questionnaires. All research was performed in accordance with the relevant guidelines and regulations. The study protocol was approved by the institutional review board and the ethics committee of Human Studies Committee of China Medical University Hospital. Written informed consent was obtained from the participants, their parent, or legal guardian in accordance with the institutional requirements and the Declaration of Helsinki principles.

SNP selection, genotyping, and quality control

We initially included genetic SNPs listed as supplementary files from previous human height GWAS14,15,16,17,18,19,20,21,22,23,24. The genetic resources for the human height GWAS are shown in Table S7. The repeated SNPs were removed and the resulting 1,033 SNPs from 14 GWAS of human height are listed in Table S1. Genotyping of these 1,033 SNPs was performed in both cases and controls. Genomic DNA was extracted from peripheral blood leukocytes according to standard protocols (Qiagen Genomic DNA Isolation Kit; Qiagen, Taichung, Taiwan). The DNA concentration and quality were confirmed on a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Taichung, Taiwan). SNPs of each sample were genotyped using a custom-designed VeraCode GoldenGate Genotyping Assay System (Illumina; http://www.illumina.com/)53,54,55. Genotypic data were quality controlled, and SNPs were excluded from further analysis if (1) the MAF was less than 5% in the controls (the Han Chinese population); (2) the total call rate was less than 95% for both cases and controls; or (3) the SNP significantly departed from Hardy-Weinberg equilibrium proportions for the controls (p < 0.05). Then SNPs that passed the correction test were considered to be significant (P = 0.05/1,033 = 0.00005).

Statistical analysis

Hardy-Weinberg equilibrium for genotype distributions of controls in this study was evaluated by the goodness-of-fit χ2 test (Table 1).

Alleles were identified by genotyping and direct counting. The difference of allelic frequency in the additive model between the cases and controls were measured by ORs with 95% CIs using logistical regression models (Table 2). Deviation from the additive model was also tested for 34 selected SNPs and a p-value for the DOMDEV test <1.47 × 10−3 was considered significant (p = 0.05/34) (Table S2). All statistical analyses were performed in the SPSS software, v12.0 for Windows (IBM, Armonk, NY, USA).

For the analysis of haplotype blocks, we used the Lewontin D′ and R2 measure to evaluate the intermarker coefficient of linkage disequilibrium in both controls and FSS cases56. The confidence interval for LD was estimated using a resampling procedure and was used to construct the haplotype blocks57, 58.

References

  1. 1.

    Paciorek, C. J., Stevens, G. A., Finucane, M. M. & Ezzati, M. Nutrition Impact Model Study, G. Children’s height and weight in rural and urban populations in low-income and middle-income countries: a systematic analysis of population-representative data. Lancet Glob Health 1, e300–309, doi:10.1016/S2214-109X(13)70109-8 (2013).

  2. 2.

    Izard, R. M., Fraser, W. D., Negus, C., Sale, C. & Greeves, J. P. Increased density and periosteal expansion of the tibia in young adult men following short-term arduous training. Bone 88, 13–19, doi:10.1016/j.bone.2016.03.015 (2016).

  3. 3.

    Tarquinio, D. C. et al. Growth failure and outcome in Rett syndrome: specific growth references. Neurology 79, 1653–1661, doi:10.1212/WNL.0b013e31826e9a70 (2012).

  4. 4.

    Bali, D. S., Chen, Y. T., Austin, S. & Goldstein, J. L. In GeneReviews(R) (eds R. A. Pagon et al.) (1993).

  5. 5.

    Gunnell, D. et al. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23, 313–342 (2001).

  6. 6.

    Stawerska, R. et al. Prevalence of autoantibodies against some selected growth and appetite-regulating neuropeptides in serum of short children exposed to Candida albicans colonization and/or Helicobacter pylori infection: the molecular mimicry phenomenon. Neuro Endocrinol Lett 36, 458–464 (2015).

  7. 7.

    Bejerman, N. et al. Complete genome sequence of a new enamovirus from Argentina infecting alfalfa plants showing dwarfism symptoms. Arch Virol 161, 2029–2032, doi:10.1007/s00705-016-2854-3 (2016).

  8. 8.

    Lettre, G. Recent progress in the study of the genetics of height. Hum Genet 129, 465–472, doi:10.1007/s00439-011-0969-x (2011).

  9. 9.

    Lanktree, M. B. et al. Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet 88, 6–18, doi:10.1016/j.ajhg.2010.11.007 (2011).

  10. 10.

    Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era–concepts and misconceptions. Nat Rev Genet 9, 255–266, doi:10.1038/nrg2322 (2008).

  11. 11.

    Plenge, R. M. et al. TRAF1-C5 as a risk locus for rheumatoid arthritis–a genomewide study. N Engl J Med 357, 1199–1209, doi:10.1056/NEJMoa073491 (2007).

  12. 12.

    Weeks, D. E. et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75, 174–189, doi:10.1086/422476 (2004).

  13. 13.

    Samani, N. J. et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357, 443–453, doi:10.1056/NEJMoa072366 (2007).

  14. 14.

    Lango Allen, H. et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467, 832–838, doi:10.1038/nature09410 (2010).

  15. 15.

    Lettre, G. et al. Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet 40, 584–591, doi:10.1038/ng.125 (2008).

  16. 16.

    Wood, A. R. et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet 46, 1173–1186, doi:10.1038/ng.3097 (2014).

  17. 17.

    Weedon, M. N. et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 40, 575–583, doi:10.1038/ng.121 (2008).

  18. 18.

    Kim, J. J. et al. Identification of 15 loci influencing height in a Korean population. J Hum Genet 55, 27–31, doi:10.1038/jhg.2009.116 (2010).

  19. 19.

    Okada, Y. et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet 19, 2303–2312, doi:10.1093/hmg/ddq091 (2010).

  20. 20.

    Gudbjartsson, D. F. et al. Many sequence variants affecting diversity of adult human height. Nat Genet 40, 609–615, doi:10.1038/ng.122 (2008).

  21. 21.

    Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet 44, 369–375, S361–363, doi:10.1038/ng.2213 (2012).

  22. 22.

    Cho, Y. S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41, 527–534, doi:10.1038/ng.357 (2009).

  23. 23.

    Chan, Y. et al. Genome-wide Analysis of Body Proportion Classifies Height-Associated Variants by Mechanism of Action and Implicates Genes Important for Skeletal Development. Am J Hum Genet 96, 695–708, doi:10.1016/j.ajhg.2015.02.018 (2015).

  24. 24.

    Soranzo, N. et al. Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet 5, e1000445, doi:10.1371/journal.pgen.1000445 (2009).

  25. 25.

    He, M. et al. Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci. Hum Mol Genet 24, 1791–1800, doi:10.1093/hmg/ddu583 (2015).

  26. 26.

    Lindsay, R., Feldkamp, M., Harris, D., Robertson, J. & Rallison, M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125, 29–35, doi:S0022-3476(94)70117-2 [pii] (1994).

  27. 27.

    Moore, K. C., Donaldson, D. L., Ideus, P. L., Gifford, R. A. & Moore, W. V. Clinical diagnoses of children with extremely short stature and their response to growth hormone. J Pediatr 122, 687–692 (1993).

  28. 28.

    Sisley, S., Trujillo, M. V., Khoury, J. & Backeljauw, P. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J Pediatr 163, 1045–1051, doi:10.1016/j.jpeds.2013.04.002 (2013).

  29. 29.

    Wang, Y. et al. An SNP of the ZBTB38 gene is associated with idiopathic short stature in the Chinese Han population. Clin Endocrinol (Oxf) 79, 402–408, doi:10.1111/cen.12145 (2013).

  30. 30.

    Filion, G. J. et al. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 26, 169–181, doi:10.1128/MCB.26.1.169-181.2006 (2006).

  31. 31.

    Kiefer, H. et al. ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons. Mol Cell Biol 25, 1713–1729, doi:10.1128/MCB.25.5.1713-1729.2005 (2005).

  32. 32.

    Hao, Y. et al. Genome-wide association study in Han Chinese identifies three novel loci for human height. Hum Genet 132, 681–689, doi:10.1007/s00439-013-1280-9 (2013).

  33. 33.

    Inagaki, H. et al. A large DNA-binding nuclear protein with RNA recognition motif and serine/arginine-rich domain. J Biol Chem 271, 12525–12531 (1996).

  34. 34.

    Ganss, B. & Jheon, A. Zinc finger transcription factors in skeletal development. Crit Rev Oral Biol Med 15, 282–297 (2004).

  35. 35.

    Meruvu, S., Hugendubler, L. & Mueller, E. Regulation of adipocyte differentiation by the zinc finger protein ZNF638. J Biol Chem 286, 26516–26523, doi:10.1074/jbc.M110.212506 (2011).

  36. 36.

    Du, C., Ma, X., Meruvu, S., Hugendubler, L. & Mueller, E. The adipogenic transcriptional cofactor ZNF638 interacts with splicing regulators and influences alternative splicing. J Lipid Res 55, 1886–1896, doi:10.1194/jlr.M047555 (2014).

  37. 37.

    Hirschhorn, J. N. & Lettre, G. Progress in genome-wide association studies of human height. Horm Res 71(Suppl 2), 5–13, doi:10.1159/000192430 (2009).

  38. 38.

    Lindholm-Perry, A. K. et al. Association, effects and validation of polymorphisms within the NCAPG - LCORL locus located on BTA6 with feed intake, gain, meat and carcass traits in beef cattle. BMC Genet 12, 103, doi:10.1186/1471-2156-12-103 (2011).

  39. 39.

    Takasuga, A. PLAG1 and NCAPG-LCORL in livestock. Anim Sci J 87, 159–167, doi:10.1111/asj.12417 (2016).

  40. 40.

    Tozaki, T. et al. Sequence variants of BIEC2-808543 near LCORL are associated with body composition in Thoroughbreds under training. J Equine Sci 27, 107–114, doi:10.1294/jes.27.107 (2016).

  41. 41.

    Wu, C. L. et al. Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers. Cancer Res 61, 7325–7332 (2001).

  42. 42.

    Zukerberg, L. R. et al. Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer. Cancer Res 64, 202–208 (2004).

  43. 43.

    Dong, Q. et al. Loss of cables, a novel gene on chromosome 18q, in ovarian cancer. Mod Pathol 16, 863–868, doi:10.1097/01.MP.0000084434.88269.0A (2003).

  44. 44.

    Park, D. Y. et al. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol 171, 1509–1519, doi:10.2353/ajpath.2007.070331 (2007).

  45. 45.

    Tan, D. et al. Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study. Hum Pathol 34, 143–149, doi:10.1053/hupa.2003.26 (2003).

  46. 46.

    Shi, Z. et al. Cables1 complex couples survival signaling to the cell death machinery. Cancer Res 75, 147–158, doi:10.1158/0008-5472.CAN-14-0036 (2015).

  47. 47.

    Kasten, M. & Giordano, A. Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20, 1832–1838, doi:10.1038/sj.onc.1204295 (2001).

  48. 48.

    Sergere, J. C., Thuret, J. Y., Le Roux, G., Carosella, E. D. & Leteurtre, F. Human CDK10 gene isoforms. Biochem Biophys Res Commun 276, 271–277, doi:10.1006/bbrc.2000.3395 (2000).

  49. 49.

    Paushkin, S. V., Patel, M., Furia, B. S., Peltz, S. W. & Trotta, C. R. Identification of a human endonuclease complex reveals a link between tRNA splicing and pre-mRNA 3′ end formation. Cell 117, 311–321 (2004).

  50. 50.

    Cassandrini, D. et al. Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology 75, 1459–1464, doi:10.1212/WNL.0b013e3181f88173 (2010).

  51. 51.

    Breuss, M. W. et al. Autosomal-Recessive Mutations in the tRNA Splicing Endonuclease Subunit TSEN15 Cause Pontocerebellar Hypoplasia and Progressive Microcephaly. Am J Hum Genet 99, 228–235, doi:10.1016/j.ajhg.2016.05.023 (2016).

  52. 52.

    Alazami, A. M. et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep 10, 148–161, doi:10.1016/j.celrep.2014.12.015 (2015).

  53. 53.

    Tindall, E. A. et al. Interpretation of custom designed Illumina genotype cluster plots for targeted association studies and next-generation sequence validation. BMC Res Notes 3, 39, doi:10.1186/1756-0500-3-39 (2010).

  54. 54.

    Lin, Y. J. et al. Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children. PLoS One 8, e81384, doi:10.1371/journal.pone.0081384 (2013).

  55. 55.

    Lin, Y. J. et al. Coronary artery aneurysms occurrence risk analysis between Kawasaki disease and LRP1B gene in Taiwanese children. Biomedicine (Taipei) 4, 10, doi:10.7603/s40681-014-0010-5 (2014).

  56. 56.

    Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265, doi:10.1093/bioinformatics/bth457 (2005).

  57. 57.

    Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225–2229, doi:10.1126/science.1069424 (2002).

  58. 58.

    Lin, Y. J. et al. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum 60, 604–610, doi:10.1002/art.24261 (2009).

Download references

Acknowledgements

This study was supported by grants from the China Medical University (CMU102-PH-01), the China Medical University Hospital (DMR-105-031 and DMR-105-098), the National Science Council, the Ministry of Science and Technology, Taiwan (NSC 102-2314-B-039 -011 -MY3, MOST 103-2320-B-039 -006 -MY3, and MOST 105-2314-B-039 -037 -MY3), and China Medical University under the Aim for Top University Plan of the Ministry of Education, Taiwan. We thank the National Center for Genome Medicine of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, for technical and bioinformatics support. We also thank Drs. Kuan-Teh Jeang and Willy W.L. Hong for technical help and suggestions.

Author information

Y.J.L., W.L.L., and F.J.T. conceived of and designed the experiments. W.L.L., C.H.T., J.H.C., W.K.C., T.H.L., C.M.W., C.C.L., and S.M.H. conducted the experiments. W.L.L., W.M.L., A.R.H., C.F.C., J.H.C., and W.K.C. analyzed the data. C.H.W., L.P.T., C.H.C., and J.Y.W. contributed reagents, materials, and analytical tools. Y.J.L. wrote the manuscript. All the coauthors have read and approved the final version of the manuscript.

Correspondence to Fuu-Jen Tsai.

Ethics declarations

Competing Interests

The authors declare that they have no competing interests.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Further reading

  • A QTL on chromosome 3q23 influences processing speed in humans

    • Emma E. M. Knowles
    • , Samuel R. Mathias
    • , Josephine Mollon
    • , Amanda Rodrigue
    • , Marinka M. G. Koenis
    • , Thomas D. Dyer
    • , Harald H. H. Goring
    • , Joanne E. Curran
    • , Rene L. Olvera
    • , Ravi Duggirala
    • , Laura Almasy
    • , John Blangero
    •  & David C. Glahn

    Genes, Brain and Behavior (2019)

  • Complex Phenotypes: Mechanisms Underlying Variation in Human Stature

    • Pushpanathan Muthuirulan
    •  & Terence D. Capellini

    Current Osteoporosis Reports (2019)

  • CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays

    • Christian Windpassinger
    • , Juliette Piard
    • , Carine Bonnard
    • , Majid Alfadhel
    • , Shuhui Lim
    • , Xavier Bisteau
    • , Stéphane Blouin
    • , Nur’Ain B. Ali
    • , Alvin Yu Jin Ng
    • , Hao Lu
    • , Sumanty Tohari
    • , S. Zakiah A. Talib
    • , Noémi van Hul
    • , Matias J. Caldez
    • , Lionel Van Maldergem
    • , Gökhan Yigit
    • , Hülya Kayserili
    • , Sameh A. Youssef
    • , Vincenzo Coppola
    • , Alain de Bruin
    • , Lino Tessarollo
    • , Hyungwon Choi
    • , Verena Rupp
    • , Katharina Roetzer
    • , Paul Roschger
    • , Klaus Klaushofer
    • , Janine Altmüller
    • , Sudipto Roy
    • , Byrappa Venkatesh
    • , Rudolf Ganger
    • , Franz Grill
    • , Farid Ben Chehida
    • , Bernd Wollnik
    • , Umut Altunoglu
    • , Ali Al Kaissi
    • , Bruno Reversade
    •  & Philipp Kaldis

    The American Journal of Human Genetics (2017)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.